Cambium Bio Limited
CMB
Ранг среди акций
#32451
Cambium Bio Limited, a clinical-stage regenerative medicine company, focuses on... Cambium Bio Limited, a clinical-stage regenerative medicine company, focuses on developing biologics for ophthalmology and tissue repair applications. The company provides lead product candidate is Elate Ocular for the treatment of dry eye disease. The company also develops Progenza, a stem cell platform for knee osteoarthritis and other tissue repair indications; and Sygenus, for wound healing indications. Cambium Bio Limited is headquartered in Bella Vista, Australia.
Цена акции
$0.31613178
Последняя синхронизация: 2026-10-21
Рыночная капитализация
$9.30M
Изменение (1 день)
-0.39%
Изменение (1 год)
5,893.70%
Страна
AU
Торговля Cambium Bio Limited (CMB)
Категория
Healthcare
История цены акций Cambium Bio Limited (CMB)
Наивысшая цена закрытия: $0.01 2024-05-01
Наименьшая цена закрытия: $0.25 2013-09-01
Наименьшая цена закрытия: $0.25 2013-09-01
История цены акций Cambium Bio Limited с 2013 по 2026
Годовая динамика цены акций
| Год | Результативность |
|---|---|
| 2024 | 119.50% |
| 2023 | -92.08% |
| 2022 | -41.49% |
| 2021 | -42.78% |
| 2020 | 56.83% |
| 2019 | -53.42% |
| 2018 | 31.72% |
| 2017 | -21.51% |
| 2016 | 74.18% |
| 2015 | -41.39% |
| 2014 | -67.54% |
| 2013 | 0.00% |
Цена акций похожих компаний или конкурентов
| Компания | Цена акций | Изменение 1г% | Страна |
|---|---|---|---|
| $536.13 | 25.72% |
US
|
|
| $200.12 | 645.31% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $291.76 | 2.51% |
BE
|
|
| $880.01 | 8.09% |
NL
|
